Bury your nose in tales of neurosyphilis, gender identity, the medical mysteries of sleep disorders, and more.

Preliminary findings from a clinical trial of heavy drinkers suggest that the drug can weaken certain memories tied to the reward of imbibing, although the mechanisms aren’t fully clear.

Kamran Khodakhah, a researcher at the Albert Einstein College of Medicine, explains the cerebellum's newly described role in addictive and social behaviors.

The Albert Einstein College of Medicine neuroscientist has revealed surprising functions of the brain region, such as its role in the brain’s rewards circuits and in addiction.

The author of a new book about emerging concepts in human genetics considers the question.

Oklahoma dropped its lawsuit against OxyContin-maker Purdue Pharma in exchange for a National Center for Addiction Studies and Treatment in Tulsa.

With a built-in supply of a powerful cocaine-chomping enzyme, the transplant might also curb addiction.

Lucemyra is the first non-opioid drug to be approved in the U.S. specifically for this purpose.

Take a break from the bench to puzzle and peruse.